Activation of heteroliganded mouse muscle nicotinic receptors

Journal of Physiology

Volumn 564, Issue 2, 2005, Pages 359-376

  Akk, Gustav ^a   Milescu, Lorin S ^b   Heckmann, Manfred ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBACHOL; CHOLINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA; NICOTINIC RECEPTOR BETA; NICOTINIC RECEPTOR DELTA; NICOTINIC RECEPTOR EPSILON; UNCLASSIFIED DRUG;

AGONIST; AMPLITUDE MODULATION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; IN VIVO STUDY; ION CURRENT; LIGAND BINDING; LIGATION; MEMBRANE TRANSPORT; MOUSE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PATCH CLAMP; PIEZOELECTRICITY; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN INTERACTION; RECEPTOR OCCUPANCY; RECORDING; STEADY STATE; SYNAPTIC TRANSMISSION; ACTION POTENTIAL AMPLITUDE; ADULT; BINDING SITE; EMBRYO; HUMAN; HUMAN CELL; RECEPTOR AFFINITY; SINGLE CHANNEL PATCH CLAMP;

ANIMALS; CARBACHOL; CELL LINE; CHOLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIGANDS; MICE; MUSCLE CELLS; NEUROMUSCULAR JUNCTION; NICOTINIC AGONISTS; RECEPTORS, NICOTINIC;

EID: 17844394461     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.078535     Document Type: Article

References (50)

1. Adams PR (1976). Drug blockade of open end-plate channels. J Physiol 260, 531-552.
2. Akk G (2002). Contributions of the non-α subunit residues (loop D) to agonist binding and channel gating in the muscle nicotinic acetylcholine receptor. J Physiol 544, 695-705.
3. Akk G & Auerbach A (1996). Inorganic, monovalent cations compete with agonists for the transmitter binding site of nicotinic acetylcholine receptors. Biophys J 70, 2652-2658.
4. Akk G & Auerbach A (1999). Activation of muscle nicotinic acetylcholine receptor channels by nicotinic and muscarinic agonists. Br J Pharmacol 128, 1467-1476.
5. Akk G & Steinbach JH (2000). Structural elements near the C-terminus are responsible for changes in nicotinic receptor gating kinetics following patch excision. J Physiol 527, 405-417.
6. Akk G & Steinbach JH (2003). Activation and block of mouse muscle-type nicotinic receptors by tetraethylammonium. J Physiol 551, 155-168.
7. Akk G & Steinbach JH (2005). Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site. J Neurosci 25, 1992-2001.
8. Auerbach A & Akk G (1998). Desensitization of mouse nicotinic acetylcholine receptor channels: a two-gate mechanism. J General Physiol 112, 181-197.
9. Auerbach A, Sigurdson W, Chen J & Akk G (1996). Voltage dependence of mouse acetylcholine receptor gating: different charge movements in di-, mono- and unliganded receptors. J Physiol 494 155-170.
10. Avalos M, Parker MJ, Maddox FN, Carroll FI & Luetje CW (2002). Effects of pyridine ring substitutions on affinity, efficacy, and subtype selectivity of neuronal nicotinic receptor agonist epibatidine. J Pharmacol Exp Ther 302, 1246-1252.
11. Bradley RJ, Sterz R & Peper K (1986). Agonist and inhibitory effects of pyridostigmine at the neuromuscular junction. Brain Res 376, 199-203.
12. Bufler J, Kahlert S, Tzartos S, Toyka KV, Maelicke A & Franke C (1996). Activation and blockade of mouse muscle nicotinic channels by antibodies directed against the binding site of the acetylcholine receptor. J Physiol 492, 107-114.
13. Colquhoun D & Hawkes AG (1977). Relaxation and fluctuations of membrane currents that flow through drug-operated channels. Proc R Soc Lond B 199, 231-262.
14. Colquhoun D & Sakmann B (1985). Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle end-plate. J Physiol 369, 501-557.
15. Croxen R, Newland C, Beeson D, Oosterhuis H, Chauplannaz G, Vincent A & Newsom-Davis J (1997). Mutations in different functional domains of the human muscle acetylcholine receptor α subunit in patients with the slow-channel congenital myasthenic syndrome. Hum Mol Genet 6, 767-774.
16. Fletcher GH & Steinbach JH (1996). Ability of nondepolarizing neuromuscular blocking drugs to act as partial agonists at fetal and adult mouse muscle nicotinic receptors. Mol Pharmacol 49, 938-947.
17. Franke C, Parnas H, Hovav G & Dudel J (1993). A molecular scheme for the reaction between acetylcholine and nicotinic channels. Biophys J 64, 339-356.
18. Hamill OP, Marty A, Neher E, Sakmann B & Sigworth FJ (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391 85-100.
19. Heckmann M & Pawlu C (2002). Fast-drug application. In Neuromethods, Vol 35, Patch-Clamp Analysis: Advanced Techniques , ed.: Walz W, Boulton AA & Baker GB, pp. 217-229. Humana Press Inc, Totowa, NJ.
20. + channel pore through mutant cycles with a peptide inhibitor. Science 268, 307-310.
21. Horovitz A & Fersht AR (1990). Strategy for analysing the co-operativity of intramolecular interactions in peptides and proteins. J Mol Biol 214, 613-617.
22. Lindstrom JM (2003). Nicotinic acetylcholine receptors of muscles and nerves: comparison of their structures, functional roles, and vulnerability to pathology. Ann N Y Acad Sci 998, 41-52.
23. Liu Y & Dilger JP (1991). Opening rate of acetylcholine receptor channels. Biophys J 60, 424-432.
24. Liu Y & Dilger JP (1993). Decamethonium is a partial agonist at the nicotinic acetylcholine receptor. Synapse 13, 57-62.
25. Maconochie DJ & Steinbach JH (1998). The channel opening rate of adult- and fetal-type mouse muscle nicotinic receptors activated by acetylcholine. J Physiol 506, 53-72.
26. Maelicke A, Schrattenholz A, Samochocki M, Radina M & Albuquerque EX (2000). Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease. Behav Brain Res 113, 199-206.
27. Magleby KL & Stevens CF (1972). A quantitative description of end-plate currents. J Physiol 223, 173-197.
28. Milescu LS, Akk G & Sachs F (2005). Maximum likelihood estimation of ion channel kinetics from macroscopic currents. Biophys J in press.
29. Neher E & Steinbach JH (1978). Local anaesthetics transiently block currents through single acetylcholine-receptor channels. J Physiol 277, 153-176.
30. Ogden DC & Colquhoun D (1985). Ion channel block by acetylcholine, carbachol and suberyldicholine at the frog neuromuscular junction. Proc R Soc Lond B 225, 329-355.
31. Paradiso KG & Steinbach JH (2003). Nicotine is highly effective at producing desensitization of rat α4β4 neuronal nicotinic receptors. J Physiol 553, 857-871.
32. Pereira EF, Hilmas C, Santos MD, Alkondon M, Maelicke A & Albuquerque EX (2002). Unconventional ligands and modulators of nicotinic receptors. J Neurobiol 53, 479-500.
33. Pereira EF, Reinhardt-Maelicke S, Schrattenholz A, Maelicke A & Albuquerque EX (1993). Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons. J Pharmacol Exp Ther 265, 1474-1491.
34. Prince RJ, Pennington RA & Sine SM (2002). Mechanism of tacrine block at adult human muscle nicotinic acetylcholine receptors. J General Physiol 120, 369-393.
35. Prince RJ & Sine SM (1998). Epibatidine activates muscle acetylcholine receptors with unique site selectivity. Biophys J 75, 1817-1827.
36. Qin F, Auerbach A & Sachs F (1996). Estimating single-channel kinetic parameters from idealized patch-clamp data containing missed events. Biophys J 70, 264-280.
37. Reitstetter R, He DS & Gruener R (1994). Oxotremorine-M activates single nicotinic acetylcholine receptor channels in cultured Xenopus myocytes. Eur J Pharmacol 264, 27-32.
38. Sakmann B, Patlak J & Neher E (1980). Single acetylcholine-activated channels show burst-kinetics in presence of desensitizing concentrations of agonist. Nature 286, 71-73.
39. Salamone FN, Zhou M & Auerbach A (1999). A re-examination of adult mouse nicotinic acetylcholine receptor channel activation kinetics. J Physiol 516, 315-330.
40. Savendahl L, Mar MH, Underwood LE & Zeisel SH (1997). Prolonged fasting in humans results in diminished plasma choline concentrations but does not cause liver dysfunction. Am J Clin Nutr 66, 622-625.
41. Schrattenholz A, Pereira EF, Roth U, Weber KH, Albuquerque EX & Maelicke A (1996). Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol Pharmacol 49, 1-6.
42. Sine SM & Steinbach JH (1984). Agonists block currents through acetylcholine receptor channels. Biophys J 46, 277-283.
43. Steinbach JH & Chen Q (1995). Antagonist and partial agonist actions of d-tubocurarine at mammalian muscle acetylcholine receptors. J Neurosci 15, 230-240.
44. Storch A, Schrattenholz A, Cooper JC, Abdel Ghani EM, Gutbrod O, Weber KH et al. (1995). Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells. Eur J Pharmacol 290, 207-219.
45. Uteshev VV, Meyer EM & Papke RL (2003). Regulation of neuronal function by choline and 4OH-GTS-21 through α7 nicotinic receptors. J Neurophysiol 89, 1797-1806.
46. Wang HL, Auerbach A, Bren N, Ohno K, Engel AG & Sine SM (1997). Mutation in the M1 domain of the acetylcholine receptor α subunit decreases the rate of agonist dissociation. J General Physiol 109, 757-766.
47. Zhao L, Kuo YP, George AA, Peng JH, Purandare MS, Schroeder KM, Lukas RJ & Wu J (2003). Functional properties of homomeric, human α7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line. J Pharmacol Exp Ther 305, 1132-1141.
48. Zhou M, Engel AG & Auerbach A (1999). Serum choline activates mutant acetylcholine receptors that cause slow channel congenital myasthenic syndromes. Proc Natl Acad Sci U S A 96, 10466-10471.
49. Zwart R, van Kleef RG, Gotti C, Smulders CJ & Vijverberg HP (2000). Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs. J Neurochem 75, 2492-2500.
50. Zwart R & Vijverberg HP (2000). Potentiation and inhibition of neuronal α4β4 nicotinic acetylcholine receptors by choline. Eur J Pharmacol 393, 209-214.